Sign up to save your podcasts
Or
Share Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
11 ratings
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Oncology in conversation with
View all
Nature Podcast
761 Listeners
Science Magazine Podcast
809 Listeners
JAMA Editors' Summary
128 Listeners
TED Talks Daily
11,256 Listeners
NEJM Interviews
125 Listeners
6 Minute English
1,761 Listeners
NEJM This Week
318 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
480 Listeners
ASCO Daily News
55 Listeners
ASCO Guidelines
44 Listeners
The Readout Loud
317 Listeners
The Uromigos
57 Listeners
The Lancet Voice
22 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Psychiatry in conversation with
1 Listeners
The Lancet Respiratory Medicine in conversation with
1 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Healthy Longevity in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
eBioMedicine in conversation with
0 Listeners
eClinicalMedicine in conversation with
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Two Onc Docs
166 Listeners
The Lancet Regional Health in conversation with
0 Listeners